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Abstract
It was found that the hypochlorous acid (HOCl) inhibits the active efflux of glutathione S-conjugates, 2,4-dinitrophenyl-S-glutathione
(DNP-SG, c50% = 258F 24 AM HOCl) and bimane-S-glutathione (B-SG, c50% = 125F 16 AM HOCl) from human erythrocytes, oxidises
intracellular reduced glutathione (the ratio [HOCl]/[GSH]oxidized = 4) and inhibits basal as well as 2,4-dinitrophenol- (DNP) and 2,4-
dinitrophenyl-S-glutathione (DNP-SG)-stimulated Mg2 + -ATPase activities of erythrocyte membranes. Multidrug resistance-associated
protein (MRP1) mediates the active export of glutathione S-conjugates in mammalian cells, including human erythrocytes. A direct
impairment of erythrocyte membrane MRP by hypochlorous acid was shown by electrophoresis and immunoblotting (c50% = 478F 36 AM
HOCl). The stoichiometry of the MRP/HOCl reaction was 1:1. These results demonstrate that MRP can be one of the cellular targets for the
inflammatory mediator hypochlorous acid.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Hypochlorous acid (HOCl) is a highly reactive bio-
logical oxidant and is thought to play an important role in
both microbial killing (bactericidal action of phagocytic
cells) and inflammatory tissue injury by neutrophils [1,2].
Stimulated neutrophils and monocytes, cells present under
inflammatory conditions, produce HOCl in substantial
amounts via the myeloperoxidase-catalysed reaction of
H2O2 with Cl
 . HOCl/OCl  can be found at concen-
trations up to 200 AM in some tissues under pathological
conditions [3]. HOCl reacts with a wide range of bio-
logical target molecules including lipids, proteins and
DNA, to form long-lived chloramines on reaction with
amine groups. Chloramines are powerful oxidising agents
and are thus extremely toxic to mammalian cells [4–6].
HOCl has been implicated in the injury associated with
neutrophil accumulation in myocardial reperfusion injury,
inflammatory disease and rheumatoid arthritis [1,2,7].
Hypochlorous acid oxidation modifies lipoproteins and this
effect is believed to participate in the development of
atherosclerotic lesions [8].
Toxic effects of HOCl have been studied using different
types of cells [4,6–8]. HOCl can enter cells and the loss of
intracellular glutathione is an early event of cell exposure to
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this oxidant as was shown for human erythrocytes [6] and
endothelial cells [7]. It has been demonstrated that low
sublethal doses of HOCl react with cellular thiols (gluta-
thione and protein thiols) and could modulate specific cell
processes in a manner similar to that seen with H2O2 or
peroxynitrite [7,9]. The plasma membrane has been envis-
aged as one of the main targets of HOCl in the cell [10,11].
Exposure of human vein endothelial cells to HOCl causes a
decrease in cell viability, concentrations of < 25 AM HOCl
being sublethal [7]. Whereas higher concentrations of hypo-
chlorous acid cause rapid necrosis, lower amounts of this
oxidant (20–40 nmol per 1.25 105 cells) initiate apopto-
sis, as demonstrated by Vissers et al. [9] for human
umbilical-vein endothelial cells. HOCl induces caspase
activity and can modify cellular responses that are depend-
ent on various signal transduction pathways [9].
Glutathione conjugation and active transport from a cell
of glutathione S-conjugates formed (detoxification phases
II and III, respectively) are important steps of the detox-
ification pathway of many xenobiotics in different cell
types [9,12]. Similarly, active export of GSSG is the way
of elimination of this potentially deleterious compound
[12,13]. It was suggested that the glutathione S-conjugates
in human erythrocytes are exported via the multidrug
resistance-associated protein (MRP1) gene product [14].
Erythrocytes, due to their simple structure and the presence
of MRP, are a good model system for investigation of such
processes.
It has been demonstrated that peroxynitrite, formed in the
reaction of nitric oxide with superoxide and believed to be
the main agent responsible for nitric oxide toxicity, damages
MRP in the human erythrocytes, effectively inhibits the
active efflux of glutathione S-conjugates from these cells
and inhibits the erythrocyte membrane ATPase activity
stimulated by glutathione S-conjugates [15].
The aim of the present work was to examine the effect of
another highly reactive biological oxidant, hypochlorous
acid, on this important cellular transport process, viz. the
active export of glutathione-S-conjugates, from human red
blood cells (RBCs). We used erythrocytes not only as a
model system in which some of the effects of hypochlorous
acid have been characterized [4,6,10,11,16] (one can sug-
gest similar cellular events produced by HOCl for different
kind of cells), but also because these cells may be one of the
main targets for neutrophil-derived oxidants, including
HOCl, during inflammation. Hypochlorous acid-produced
impairments of erythrocytes due to direct interaction
between neutrophils and RBCs in circulation can play an
important role in the development of the long-term vascular
complications in inflammation.
The time course and stoichiometry of intracellular GSH
oxidation by HOCl, inhibition of active export of two
glutathione S-conjugates, changes in the membrane ATPase
activity linked to the process of glutathione S-conjugate
transport, and modification of erythrocyte MRP have been
studied.
2. Materials and methods
2.1. Materials
2,4-Dinitrophenol (DNP), 1-chloro-2,4-dinitrobenzene
(CDNB), 5,5V-dithiobis-(2-nitrobenzoic acid) (Ellman
reagent; DTNB), ouabain, adenosine-5-triphosphate (ATP),
ethyleneglycol-bis-(h-aminoethyl ether) N,N,NV,NV-tetraace-
tic acid (EGTA), ethylenediaminetetraacetatic acid (EDTA),
reduced glutathione (GSH), Malachite Green, sodium hypo-
chlorite, phenylmethylsulfonyl fluoride (PMSF) and anti-rat
IgG antibodies conjugated with peroxidase were obtained
from Sigma (Deisenhofen, Germany). Monochlorobimane
(mBCl) was from Molecular Probes (Eugene, USA). 2,4-
Dinitrophenyl-S-glutathione (DNP-SG) was synthesised
from CDNB and glutathione nonenzymatically [17].
Bimane-S-glutathione (B-SG) was obtained by nonenzy-
matic conjugation of mBCl to glutathione [18]. HBS cellu-
lose was from Serva (Heidelberg, Germany). Immobilon-P
was from Millipore. Anti-human MRP rat monoclonal anti-
bodies (clone MRP r1) were from Kamiya Biomedical
Company. All other chemicals were from POCh (Poland)
and were of analytical grade. All solutions were made with
water purified by the Milli-Q system (Millipore) having a
resistivity of 18.4 MV cm 2.
Human erythrocytes were obtained from fresh blood of
healthy donors anticoagulated with citrate. Erythrocytes
were isolated by centrifugation at 4 jC, 2000 g and
purified by three cycles of resuspension and washing with
20 volumes of PBS (150 mM NaCl + 10 mM phosphate
buffer, pH 7.4) containing 1 mM EDTA and 0.5 mM PMSF.
After careful removal of the buffy coat, residual leukocytes
were removed by passing erythrocyte suspensions through a
column of HBS cellulose. Erythrocyte ghosts for the deter-
mination of ATPase activity were prepared from washed
cells according to a modification of the method of Dodge et
al. [19] consisting the borate buffer instead of the phosphate
buffer (20 mM, pH 7.4) and containing 1 mM EDTA and
0.5 mM PMSF as proteolytic inhibitors during haemolysis
process.
2.2. Exposure of erythrocytes and erythrocyte ghosts to
hypochlorite
Stock solution of sodium hypochlorite was diluted three
times with PBS (or with 100 mM borate buffer, pH 7.4, for
determination of inhibition of ATPase activity). The final
concentration of hypochlorite (OCl  ) was about 30–35
mM and before each experiment was estimated spectropho-
tometrically using an absorbance coefficient of e = 350 M 1
cm  1 at 292 nm in 0.1 M NaOH [20]. Erythrocytes
obtained as described above (preincubated with CDNB or
monochlorobimane if for transport experiments) were and
resuspended in appropriate buffer at haematocrits of 5%,
10%, or 20% were added with different concentrations of
hypochlorite and examined for glutathione S-conjugate
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efflux or for GSH content. For the estimation of GSH
content, RBCs after incubation with hypochlorite were
washed by excess of cold PBS.
For the assay of glutathione S-conjugate-stimulated
ATPase activity, erythrocyte ghosts (protein concentration
of 3 mg/ml) were added with different concentrations of
hypochlorite in 5 mM borate buffer, pH 7.4, for 10 min and
enzymatic activity was estimated as described below. For
analysis of MRP content, erythrocyte ghosts (protein con-
centration of 3 mg/ml) were added with different concen-
trations of hypochlorite for 10 min.
2.3. Measurement of the transport of glutathione S-
conjugates
Transport of 2,4-dinitrophenyl-S-glutathione (DNP-SG)
was measured according to the procedure of Board [21].
Briefly, washed erythrocytes were resuspended in phos-
phate-buffered saline (PBS) and incubated with 1 mM
CDNB for 15 min at 37 jC to form intracellular 2,4-
dinitrophenyl-S-glutathione. Then, the cells were washed
for the removal of the excess of CDNB at 0 jC and
suspended at a haematocrit of 20% in the transport buffer
containing 138 mM NaCl, 5 mM KCl, 6.1 mM Na2HPO4,
1.4 mM NaH2PO4, 1 mM MgCl2 and 1 mg/ml glucose, pH
7.4. Initial concentration of DNP-SG in so treated cells was
1.65F 0.16 mmol/l cells (meanF S.D.; n = 5). The cell
suspensions were then incubated at 37 jC, treated with
hypochlorite and the export of DNP-SG was quantified by
withdrawal of aliquots of the cell suspensions after ‘‘zero-
time’’ (about 10 s), 10, 20 and 30 min, centrifugation and
estimation of absorbance of the conjugate at 340 nm in the
supernatants [21]. Haemolysis was negligible; however, in
order to exclude interference from absorbance by the
released haemoglobin, the supernatants were added with
an equal amount of 10% trichloroacetic acid (TCA),
centrifuged and absorbance of DNP-SG was read in so
obtained extracts. In order to make a correction for DNP-
SG released from cells, which haemolysed during the
experiment, absorbance of the supernatants at 540 nm
was read to estimate percent of haemolysis and the amount
of DNP-SG liberated with haemoglobin was calculated on
the basis of haemoglobin and DNP-SG content of cells at
time zero. The correction did not exceed 5% for the lower
concentrations of hypochlorite, and about 10% for 750 AM
HOCl.
Transport of B-SG through erythrocyte membranes was
made as described previously [18] with some modifications.
Briefly, human erythrocytes at the haematocrit of 50% in the
transport buffer were incubated for 5 min with 10 AM mBCl
(final concentration, mBCl was added from a stock solution
of 5 mM in ethanol) at room temperature. Then they were
suspended at a haematocrit of 5% (for some experiments of
10%, 15% and 20%) in the transport buffer, incubated at 37
jC and treated with HOCl. Initial intracellular concentration
of B-SG was 14.7F 2.8 Amol/l cells. Aliquots of the
suspensions were withdrawn after zero-time, 3, 6, 9, 12
and 15 min, centrifuged and the supernatant was added with
an equal volume of ice-cold 10% TCA for haemoglobin
removal. Haemolysis was checked and it was always below
5%. Nevertheless, a correction of each fluorescence value
for B-SG released by haemolysis (based on the determina-
tion of the amount of released haemoglobin from absorb-
ance at 540 nm) was made. Fluorescence of the supernatants
was measured in a Perkin-Elmer LS-5B fluorescence spec-
trophotometer at excitation wavelength of 386 nm and
emission wavelength of 476 nm [18].
2.4. Determination of the glutathione S-conjugate-stimu-
lated ATPase activity
ATPase activity was assayed as described elsewhere [22].
Briefly, erythrocyte membranes were incubated in the assay
medium consisting of 100 mM Tris–HCl, pH 7.4, contain-
ing 10 mM MgCl2, 2 mM ATP, 1 mM EGTA (to inhibit
Ca2 + -ATPase) and 0.1 mM ouabain (to inhibit Na + , K + -
ATPase) for 30 min at 37 jC in the absence of other
additives or in the presence of 4 mM DNP-SG or 1 mM
DNP. DNP was demonstrated to stimulate the activity of
erythrocyte membrane Mg2 + -ATPase even better then
DNP-SG [22,23]. The differences in activities in the pres-
ence and in the absence of the stimulants were referred to as
the DNP-SG-dependent and DNP-dependent ATPase activ-
ities, respectively. The inorganic phosphate liberated was
quantified with Malachite Green [24]. Protein was measured
according to the method of Lowry et al. [25].
2.5. GSH content
The concentration of GSH was determined by the
method of Ellman [26], using the absorption coefficient
13.6 mM 1 cm 1.
2.6. Electrophoresis and immunoblotting
For electrophoresis, the erythrocyte ghosts (control and
treated with hypochlorite) were solubilized with 3% SDS,
50 mM Tris–HCl buffer (pH 6.8) and 200 mM dithio-
threitol (final concentration). After incubation at 37 jC for
30 min, an aliquot of the mixture containing 25 Ag of
protein was subjected to one-dimensional SDS-polyacryla-
mide gel electrophoresis (SDS-PAGE) using the buffer
system of Laemmli [27]. The proteins bands from SDS-
PAGE gels were transferred to an Immobilon P membrane
according to the method of Towbin et al. [28]. After
blocking with 5% nonfat milk, the rat anti-MRP antibodies
(at a dilution of 1:2000), and the second anti-rat IgG
(whole molecule)-peroxidase conjugated antibody at a
dilution of 1:2000 were used. The immunoreactive bands
were visualized by the enhanced chemiluminescence (ECL)
technique, according to the instructions of the manufacturer
(Amersham). Densitometric analysis of the MRP was
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performed with a computer-assisted Desaga CD-60 densi-
tometer (Heidelberg, Germany).
All given values are means (F S.D.) of four to six
independent experiments.
3. Results
3.1. Oxidation of cellular glutathione
We have studied the kinetic parameters of glutathione
oxidation at the haematocrit used in the glutathione S-
conjugate transport experiments. Exposure of RBCs to
HOCl resulted in effective dose- and time-dependent oxi-
dation of intracellular reduced glutathione (Fig. 1). At high
(more than 0.4 mM) HOCl concentrations, the reaction
required less then 1 min for reaching the equilibrium. At
0.8 mM HOCl in the case of 20% haematocrit, complete
GSH oxidation took place. At this HOCl concentration,
some recovery of GSH at longer time of cell incubation was
observed.
3.2. Inhibition of glutathione S-conjugate transport
Treatment of RBCs with hypochlorous acid significantly
decreased the rate of extrusion of DNP-SG (Fig. 2) and B-
SG (Fig. 3) from the cells in a concentration-dependent
manner. Figs. 2 and 3 show the time course of DNP-SG and
B-SG efflux for native and HOCl-treated RBCs. Initial
transport rates during first 3 min after HOCl addition to
the RBCs were compared because nonlinearity of the time
course of B-SG efflux, in contrast to DNP-SG efflux (Figs.
2 and 3) was observed, in agreement with previous obser-
vations [15]. Hypochlorous acid concentration needed for
50% inhibition of DNP-SG efflux was 258F 24 AM while
that for 50% inhibition of B-SG efflux was 125F 16 AM.
(For studies of DNP-SG transport, RBCs were exposed to
HOCl at 20% haematocrit and for studies of B-SG transport,
at 5% haematocrit so the sensitivities of the transport of the
two conjugates cannot be directly compared). In the case of
B-SG transport, we observed some recovery-type increase
of transport rate during longer cell incubation after treatment
with higher doses of HOCl (Fig. 3). A similar phenomenon
has been previously observed after exposure of erythrocytes
to peroxynitrite [15].
3.3. Inhibition of stimulated Mg2+-ATPase activities of the
erythrocyte membranes
The activity of the glutathione S-conjugate transporter in
the erythrocyte membrane is reflected by DNP- and DNP-
SG- stimulated ATPase activities of the membrane. RBC
Fig. 1. Time course of intracellular GSH oxidation during RBC exposure to
100 AM (1), 200 AM (2), 400 AM (3), 600 AM (4) and 800 AM (5)
hypochlorite. Cells at a haematocrit of 20% were suspended in PBS, pH
7.4, at 37 jC and different HOCl concentrations were added. Data
presented as meanF S.D. (n= 3–6); in some cases, S.D. is lower than the
data points.
Fig. 2. DNP-SG efflux from human erythrocytes in the absence (1) and in
the presence of 50 AM (2), 100 AM (3), 200 AM (4), 500 AM (5) and 750
AM (6) hypochlorite. Erythrocytes (20% haematocrit), preloaded with
CDNB were added with hypochlorite and incubated at 37 jC. Data
presented as meanF S.D. (n= 3–6); in some cases, S.D. is lower than the
data points.
Fig. 3. B-SG efflux from human erythrocytes in the absence (1) and in the
presence of 50 AM (2), 100 AM (3), 200 AM (4), 500 AM (5) and 750 AM
(6) hypochlorite. Erythrocytes, preincubated at 50% haematocrit with
monochlorobimane, were suspended at a haematocrit of 5%, treated with
hypochlorite and incubated at 37 jC. MeanF S.D. (n= 3–6).
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membrane exposure to HOCl resulted in a dose-dependent
inhibition of the basal Mg2 + -ATPase activity as well as
DNP-SG- and DNP-stimulated Mg2 + -ATPase activities.
Hypochlorous acid concentration needed for the 50% inhib-
ition of the basal Mg2 + -ATPase activity, the DNP-SG-
stimulated Mg2 + -ATPase activity and the DNP-stimulated
activity were 245F 26, 172F 14 and 255F 28 AM, respec-
tively. Table 1 shows the effect of the hypochlorite on the
basal Mg2 + -ATPase activity and the DNP-SG- and DNP-
stimulated activities.
3.4. Changes of erythrocyte membrane potential
Because of the anionic nature of the conjugates, we have
studied the changes of RBC membrane potential as a
possible mechanism of HOCl influence on the glutathione
S-conjugate transport. Even at high oxidant concentrations
inducing cell haemolysis, we did not observed any signifi-
cant changes of the membrane potential (Table 1).
3.5. Immunological identification of MRP1 in hypochlorous
acid-treated RBC membranes
Using the method of immunoblotting with rat anti-MRP1
serum, MRP1 was detected in electrophoregrams of RBC
membranes in the 200 kDa molecular weight range before
Table 1
Effect of hypochlorite on the basal Mg2 + -ATPase and ATPase activity stimulated by DNP-SG and DNP, and on the RBC membrane potential
Hypochlorite concentration 0 (control) 50 AM 100 AM 200 AM 500 AM 750 AM
Mg2 + -ATPase 187F 13 ( = 100%) 159F 7 ( = 85%) 130F 18 ( = 70%) 111F 8 ( = 59%) 52F 4 ( = 28%) 36F 11 ( = 19%)
DNP-SG-stimulated activity 71F19 ( = 100%) 61F12 ( = 86%) 35F 11 ( = 49%) 10F 5 ( = 14%) 11F 5 ( = 15%) 5F 3 ( = 7%)
DNP-stimulated activity 178F 13 ( = 100%) 150F 11 ( = 84%) 144F 16 ( = 81%) 113F 8 ( = 63%) 54F 12 ( = 30%) 34F 8 ( = 19%)
RBC membrane potential  13.1F 0.6  13.2F 0.9  13.2F 0.8  12.6F 0.8  12.1F 0.7 n.d.
ATPase activity expressed in nmol Pi/(mg protein h); erythrocyte ghosts (3 mg protein/ml) were incubated with hypochlorite. DNP (DNP-SG)-stimulated
ATPase activity = activity measured in the presence of DNP (DNP-SG) minus activity measured without the stimulant. RBC membrane potential expressed in
mV; RBCs (10% haematocrit) in PBS, pH 7.4 were treated with different HOCl concentrations for 10 min at 22 jC and washed before measurement.
MeanF S.D., n= 3.
Fig. 4. Analysis of MRP content in the erythrocyte membranes treated with
hypochlorite: (A) Immunoblotting of the control RBS membranes and
membranes treated with 50 AM (a), 100 AM (b), 200 AM (c), 300 AM (d),
500 AM (e), 750 AM (f), 1000 AM (g) and 1500 AM hypochlorite (h) using
anti-MRP monoclonal antibodies. (B) The same Immobilon sheet was
stained for protein identification with Sudan Black. The main RBC
membrane proteins and their molecular masses are indicated.
Fig. 5. Decrease of the content of immunoreactive MRP after RBC
membrane treatment with hypochlorite: (a) Dependence of immunoreactive
MRP band area on HOCl concentration. (b) The same dependence,
linearised according to the Hill equation.
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and after membrane exposure to HOCl (Fig. 4A). Simulta-
neously, the main erythrocyte membrane proteins were
identified on the immunoblots (Fig. 4B). Cell membrane
treatment with hypochlorite resulted in a significant disap-
pearance of the immunoreactive MRP1 (Figs. 4A and 5).
Fig. 5a shows densitometric analysis of the MRP1 content
in the RBC membranes after exposure to hypochlorite. At
the same time, disappearance of the main membrane pro-
teins was also observed (Fig. 4B).
4. Discussion
ATP-dependent glutathione S-conjugate export from
human erythrocytes has two kinetic components, one of
high affinity (Km= 7.4F 0.2 Amol/ml cells, in the case of B-
SG transport) and low capacity and another of low affinity
(Km = 242F 8 Amol/ml cells for B-SG) and high capacity
[18]. Recently, the MRP1 gene product was identified as an
ATP-dependent export pump for glutathione S-conjugates in
human erythrocytes as well as in the other cell types
[14,29–32]. MRP1 is a membrane glycoprotein of apparent
molecular mass of 190 kDa, belonging to the ATP-binding
cassette (ABC) protein family [29,31,33].
In the present study, we investigated whether modifica-
tion of erythrocyte membrane MRP by hypochlorous acid
may lead to inhibition of glutathione S-conjugate transport
across the membrane. The first step of our work was the
investigation of GSH oxidation (GSH is the substrate for the
conjugation reaction and GSSG formed by GSH oxidation
is also the substrate for the transporter). It is known that
HOCl easily penetrates the red cell membrane and highly
selectively oxidizes intracellular GSH [6]. In agreement
with the observation of Vissers and Winterbourn [6], we
found that the loss of GSH is a very fast process and
requires less than 1 min for attaining equilibrium (Fig. 1).
We observed some recovery of GSH after cell exposure to
oxidant (Fig. 1, curve 5) due to activity of cell GSSG
reductase. At high concentrations of HOCl (higher than
0.2 mM), the ratio [HOCl]/[GSH]oxidised = 4, i.e. four mol-
ecules of HOCl were required for oxidation of one molecule
of intracellular GSH under these conditions. At lower
oxidant concentrations, this ratio was lower (two molecules
of HOCl per molecule of GSH at 0.1 mM HOCl). Earlier, it
was calculated that oxidation of intracellular GSH required
approximately 2.5 mol of HOCl per mol of GSH lost [6].
Thus, the ratio [hypochlorite]/[GSH]oxidised increases with
the increase of HOCl concentration. It was suggested by
Prutz [34] that one molecule of HOCl reacts with the
terminal a-amino-group of GSH and three molecules of
HOCl react with the SH-group.
Different GSH-oxidizing agents (H2O2, t-butyl hydro-
peroxide, phenazine methosulfate and nitrite), have been
shown to stimulate GSSG export from human erythrocytes
[13]. No relation between the ability of these agents to
stimulate GSH oxidation and GSSG export was observed,
and the sensitivity of the transporter itself to the action of
the oxidants (thiol-modifying agents) was suggested [13].
Treatment of RBCs with HOCl brings about different
interconnected processes: effective intracellular GSH oxida-
tion, stimulation of GSSG export (observed previously for
other oxidative agents [13]), as well as modification and
inhibition of the conjugate export pump, i.e. MRP1.
We have shown that hypochlorite treatment of RBCs did
not alter the membrane potential (Table 1) and thus cannot
influence the transport of anionic conjugates by changing
charge distribution at the membrane. The lack of detectable
changes in membrane potential can be explained by the
compensation of potassium leakage through the damaged
membrane by sodium influx. Such a situation may take place
if membrane pores formed by HOCl treatment are not cation
selective. Previously, we have shown that RBC treatment by
another oxidative agent, organic hydroperoxide, resulted in
considerable membrane hyperpolarization due to intensive
potassium leakage [35].
The transport of both substrates studied, DNP-SG and B-
SG, was inhibited by HOCl, that of B-SG being more prone
to inhibition. Measurements of the DNP-SG efflux from
erythrocytes given millimolar concentrations of CDNB
allow for characterisation of the low-affinity, high-capacity
transport component while monitoring the B-SG efflux from
cells treated with micromolar concentrations of monochlor-
obimane provides an insight into the activity of the high-
affinity, low-capacity component. Like in the case of inhib-
ition of glutathione S-conjugate transport by peroxynitrite
[15], one can propose that hypochlorous acid: (i) modulates
the glutathione S-conjugate pump (i.e. MRP1) itself, (ii)
causes GSH oxidation, and oxidised glutathione inhibits
glutathione S-conjugate pump as a competitive substrate.
We did not observe any significant lipid peroxidation pro-
duced by HOCl treatment (data not shown). However, HOCl
can produce lipid chlorohydrins [4] and in this way disturb
membrane lipid bilayer and affect in turn the glutathione S-
conjugate pump in the membrane.
Some organic anions, notably DNP, were shown to
stimulate membrane ATPase activity, ascribed by some
authors to the glutathione S-conjugate transporter [23].
Mg2 + -ATPase activity stimulated by DNP-SG is more
sensitive to hypochlorous acid in comparison to basal or
DNP-stimulated ATPase activities. This is in agreement with
our previous results on different sensitivity of both these
activities to radiation inactivation [37]. Glutathione S-con-
jugate pump is known to have sulfhydryl group(s) essential
for its activity [18,30,33,36]. Thus, modification of vital
sulfhydryl group(s) of MRP by HOCl may inhibit active
transport of glutathione S-conjugates. We observed differ-
ences in the sensitivity of B-SG and DNP-SG transport to
the action of HOCl. Earlier, we have shown that RBC
membrane treatment with HOCl resulted in a considerable
inhibition of Mg2 + - and Na + -, K + -ATPase activities
(responsible for other very important cell transport process),
apparently due to protein thiol group modification [16].
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It was shown by the method of radiation inactivation that
two components of 2,4-dinitrophenyl-S-glutathione trans-
port across the erythrocyte membrane (high and low affin-
ity), as well as DNP-SG-stimulated ATPase activity,
correspond to the MRP protein(s), and suggested that
MRP1 protein exist in erythrocyte membrane as a dimer
(the molecular masses of functional units were 437F 69
kDa for high-affinity component and 466F 67 kDa for low-
affinity component) [37]. It was suggested that the DNP-
stimulated activity might be linked to a different protein,
perhaps aminophospholipid translocase [37]. Electrophore-
sis and immunoblotting of MRP1 in RBC membrane after
exposure to hypochlorite by the immunoprecipitation
showed a considerable impairment of this protein by HOCl
(Figs. 4A and 5a,b). The decrease of the amount of immu-
noreactive MRP1 (the apparent molecular mass is in the
range 200 kDa) in erythrocyte membranes paralleled the
decrease of the content of main RBC membrane proteins
(Fig. 4A,B). Earlier, Vissers et al. [11] showed irreversible
cross-linking of band 3 protein as well as all other major
membrane proteins by RBC membrane exposure to HOCl
using SDS/PAGE.
The curve describing destruction of the MRP molecules
in the membrane on the HOCl concentration has a sigmoi-
dal form (Fig. 5a). The dependence of MRP degradation
on oxidant concentration was presented as a Hill plot of
log [Y/(1 Y)] versus log [HOCl], where Y is the fraction
of the destroyed MRP (i.e., the degree of saturation of
HOCl-binding sites on the MRP molecule) (Fig. 5b). The
slope of the Hill plot (the Hill coefficient n) characterizes
the cooperativity of erythrocyte membrane MRP modifi-
cation by HOCl. If the cooperativity is full, the Hill
coefficient equals to the number of ligand-binding sites.
The Hill plot intersects the abscissa axis at the half-
saturating concentration of the oxidant (ligand), which
reflects the affinity of the protein for the modifier. The
Hill coefficient calculated is equal to n = 1.1 (Fig. 5b).
Thus, one molecule of hypochlorite modified one unit of
MRP and the half-saturating concentration of hypochlorite
(the concentration of hypochlorite, needed for 50% mod-
ification of MRP) was c50% = 478F 45 AM. This value is
higher than that needed for 50% inhibition of the stimu-
lated ATPase activities, which may be due to the fact that
the disappearance of MRP is due to its crosslinking to
other membrane proteins rather than specific alteration of
the epitope by HOCl. This value is also higher than that
required for inhibition of glutathione S-conjugate efflux
but these values cannot be directly compared as the con-
ditions of exposure were different (isolated membranes vs.
whole cells).
Our results demonstrate therefore that the glutathione S-
conjugate pump can be one of the cellular targets for
hypochlorous acid and modification of MRP in the eryth-
rocyte membrane can inhibit the transport of such conju-
gates and GSSG, perpetuating the oxidative stress induced
by this oxidant.
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